Table 1.
Category | Gene Symbol | Molecular Function/Copy Number |
Molecular, Cellular and Circuit Phenotypes |
Refs |
---|---|---|---|---|
Genetic animal models | NRXNs | Synaptic adhesion molecule | ↓Glutamatergic trans. and synaptic density | [7,8,9,10] |
NLGNs | Synaptic adhesion molecule | Context-dependent impaired glutamatergic and GABAergic trans; ↓Brain volume, cerebellar deficit; ↓GABAergic trans. in D1-MSN in NAc; ↓Brain volume |
[11,12,13,14] | |
SHANK3 | Synaptic scaffolding molecule | Striatal dysfunction; ↓Activity-dependent AMPAR distribution and LTP; ↓Glutamatergic trans. by presynaptic mechanism, ↓LTP; ↓NMDAR function, Rac1, PAK, cofilin signaling defects, F-actin dysregulation in PFC | [15,16,17,18,19] | |
TSC1/2 | Translational regulator | Cerebellar deficits; Brain enlargement, hyperactive mTOR signaling, autophagy deficiency | [20,21,22] | |
FMR1 | Translational regulator | ↑mGluR function, immature protrusion; PI3K signaling, ↑spine density, impaired AMPAR-mediated synaptic plasticity; Hypersensitivity to ERK1/2 pathway activation, ↑protein synthesis; ↑Fetal or early postnatal GABA and Cl–, abnormal EEG | [23,24,25] | |
MECP2 | Translational regulator | ↓Dopamine transporter (DAT) and tyrosine hydroxylase (TH) in the striatum; Altered cortical and cerebellar volumes; Cortical LTP deficit; ↓cortical BDNF levels; Impaired PI3K/AKT/mTOR pathway; ↓CB1 and CB2 receptor levels; Hippocampal circuit dysfunction | [26,27,28,29] | |
CHD8 | Translational regulator | CHD8 regulates different sets of genes associated with ASD by direct and indirect mechanisms | [30,31,32] | |
SCN1A | Na+ channel | ↓GABAergic interneuron firing | [33] | |
SYNGAP1 | Alternative splicing | Major constituent of the PSD essential for postsynaptic signaling; SYNGAP1 regulates the postmitotic maturation of human neurons made from hiPSCs, which influences how activity develops within nascent neural networks | [34,35] | |
ADNP | Translational regulator | Potential transcription factor; mediate some of the neuroprotective peptide VIP-associated effects involving normal growth | [36] | |
ANK2 | Protein transport | endocytosis and intracellular protein transport; continuous directional cell migration | [37] | |
CUL3 | Transport | Mediate ubiquitination of target proteins; releases the GATOR1 complex-mediated inhibition of the TORC1 pathway | [38] | |
PTEN | Apoptosis | Neuron positioning, dendritic development and synapse formation | [39] | |
TBR1 | Transcription | Neuronal migration, laminar and areal identity, and axonal projection; blocks the formation of the corticospinal (CS) tract from layer 6 projection neurons | [40] | |
SCN2A | Ion transport | Mediates the voltage-dependent sodium ion permeability of excitable membranes | [41] | |
TRIP12 | DNA repair | Ubiquitin fusion degradation (UFD) pathway and | [42] | |
regulation of DNA repair | ||||
RELN | Cell adhesion | Regulates microtubule function in neurons and neuronal migration; affects migration of sympathetic preganglionic neurons in the spinal cord | [43] | |
UBE3A | Proteolysis | Acts as a regulator of synaptic development by mediating ubiquitination and degradation of ARC; Synergizes with WBP2 in enhancing PGR activity | [37] | |
Cntnap2 | Cell adhesion | Plays a role in the formation of functionally distinct domains critical for saltatory conduction of nerve impulses in myelinated nerve fibers | [44] | |
Grin2b | Ion transport | Irreversible neuronal death; neural pattern formation; long-term depression (LTD) of hippocampus membrane currents and in synaptic plasticity | [45,46] | |
Copy number variation | 15q11-q13 | Deletion | ↑excitatory synaptic event frequency amplitude, density of dendritic protrusions,↓inhibitory synaptic transmission; Impaired activity-dependent synaptic plasticity and homoeostatic synaptic scaling | [47,48] |
15q13.3 | Microdeletion | ↑endoplasmic reticulum stress; Dysregulated neuronal gene expression; ↑cholinergic activity; ↑homomeric CHRNA7 channel activity | [49,50] | |
16p11.2 | Deletion | ↑soma size and dendrite length in 16pdel neurons; ↓neuronal size and dendrite length in 16pdup neurons; ↓synaptic density | [51,52] | |
22q11.2 | Duplication | ↓spontaneous neuronal activity and calcium signalling; ↓expression of miR-1290 | [53] | |
Idiopathic animal models | BTBR-T+ tfl/J | ↓GABAergic inhibitory transmission; ↓5HT2A receptor density and activity; ↑glutamatergic transmission in cortico-striatal circuitry; Impaired dopamine D2 receptor function; ↓BDNF expression in hippocampus and cortex; Absence of corpus callosum, lack of hippocampal commissure; ↓cortical thickness; ↓cerebral white and gray matter; Impaired cortico-thalamic function; Altered volumes of cerebellum, brainstem, striatum, and hippocampus | [54,55,56,57,58,59] | |
BALB/cByJ | Interleukin change; neuroinflammation | [60] | ||
Environmental models | VPA | ↑glutamatergic excitatory signaling; Hyperexcitable local connectivity;↓parvalbumin-positive inhibitory interneurons;↑brain serotonin levels; Apical dendritic arborization complexity;↓PTEN expression and↑p-AKT protein levels in hippocampus and cortex | [61,62,63,64] | |
Maternal immune activation | Changes of various interleukins in brain | [65] |